Huaiwei Ding

980 total citations
43 papers, 814 citations indexed

About

Huaiwei Ding is a scholar working on Molecular Biology, Organic Chemistry and Pathology and Forensic Medicine. According to data from OpenAlex, Huaiwei Ding has authored 43 papers receiving a total of 814 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 14 papers in Organic Chemistry and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Huaiwei Ding's work include PI3K/AKT/mTOR signaling in cancer (14 papers), Cancer Mechanisms and Therapy (6 papers) and Quinazolinone synthesis and applications (6 papers). Huaiwei Ding is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (14 papers), Cancer Mechanisms and Therapy (6 papers) and Quinazolinone synthesis and applications (6 papers). Huaiwei Ding collaborates with scholars based in China, South Korea and Singapore. Huaiwei Ding's co-authors include Qingchun Zhao, Xiaowen Jiang, Hongrui Song, Wenwu Liu, Zihua Xu, Yongnan Xu, Yan Xiao, Xiaochun Qin, Yanhua Fan and Rui Zhang and has published in prestigious journals such as Journal of Molecular Biology, Chemical Engineering Journal and Journal of Controlled Release.

In The Last Decade

Huaiwei Ding

42 papers receiving 796 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Huaiwei Ding China 19 434 292 104 76 71 43 814
Kwan‐Young Jung South Korea 18 562 1.3× 364 1.2× 112 1.1× 45 0.6× 23 0.3× 52 975
Teresa Valero Spain 13 358 0.8× 158 0.5× 121 1.2× 27 0.4× 54 0.8× 28 671
Jinqian Liu United States 16 386 0.9× 527 1.8× 91 0.9× 128 1.7× 35 0.5× 29 1.1k
Yohei Saito Japan 21 632 1.5× 228 0.8× 214 2.1× 120 1.6× 96 1.4× 82 1.2k
Amir Faisal Pakistan 23 880 2.0× 210 0.7× 212 2.0× 44 0.6× 58 0.8× 68 1.4k
Hormoz Mazdiyasni United States 15 501 1.2× 388 1.3× 132 1.3× 120 1.6× 57 0.8× 23 1.2k
Darren McKerrecher United Kingdom 16 508 1.2× 466 1.6× 168 1.6× 42 0.6× 41 0.6× 28 1.2k
Dan Mao China 19 352 0.8× 285 1.0× 79 0.8× 49 0.6× 18 0.3× 54 893
Massimo Serra Italy 18 491 1.1× 223 0.8× 111 1.1× 63 0.8× 138 1.9× 52 925
Chi Meng China 16 255 0.6× 158 0.5× 51 0.5× 54 0.7× 51 0.7× 41 661

Countries citing papers authored by Huaiwei Ding

Since Specialization
Citations

This map shows the geographic impact of Huaiwei Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huaiwei Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huaiwei Ding more than expected).

Fields of papers citing papers by Huaiwei Ding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huaiwei Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huaiwei Ding. The network helps show where Huaiwei Ding may publish in the future.

Co-authorship network of co-authors of Huaiwei Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Huaiwei Ding. A scholar is included among the top collaborators of Huaiwei Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huaiwei Ding. Huaiwei Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Jinrui, Bowen Zhang, Shufang Zheng, et al.. (2024). Optimizing the stable doxorubicin prodrug nanocomplex for efficient and selective cancer therapy. Chemical Engineering Journal. 504. 158945–158945.
2.
Meng, Lingyu, Zheng Sun, Yulong Zhang, et al.. (2024). Structural Studies on Mycobacterial NudC Reveal a Class of Zinc Independent NADH Pyrophosphatase. Journal of Molecular Biology. 436(23). 168864–168864. 1 indexed citations
3.
Wang, Weiping, Jiaqi Fan, Yanfang Wang, et al.. (2024). Design, synthesis and evaluation of carbamate-bridged amino acid prodrugs of cycloicaritin with improved antitumor activity, aqueous solubility and phase II metabolic stability. European Journal of Medicinal Chemistry. 276. 116646–116646. 4 indexed citations
4.
Liu, Hongbing, Jingxin Gou, Tian Yin, et al.. (2023). Integration of MyD88 inhibitor into mesoporous cerium oxide nanozymes-based targeted delivery platform for enhancing treatment of ulcerative colitis. Journal of Controlled Release. 361. 493–509. 19 indexed citations
5.
Wu, Yuting, Xiangbo Xu, Mingyue Liu, et al.. (2022). DZW-310, a novel phosphoinositide 3-kinase inhibitor, attenuates the angiogenesis and growth of hepatocellular carcinoma cells via PI3K/AKT/mTOR axis. Biochemical Pharmacology. 201. 115093–115093. 8 indexed citations
6.
Xu, Zihua, et al.. (2022). Design, synthesis, and biological evaluation of β-carboline 1,3,4-oxadiazole based hybrids as HDAC inhibitors with potential antitumor effects. Bioorganic & Medicinal Chemistry Letters. 64. 128663–128663. 19 indexed citations
7.
Liu, Wenwu, Xin Liu, Yaping Gao, et al.. (2021). Design, synthesis and biological evaluation of harmine derivatives as potent GSK-3β/DYRK1A dual inhibitors for the treatment of Alzheimer's disease. European Journal of Medicinal Chemistry. 222. 113554–113554. 66 indexed citations
8.
Zhang, Han, Qingbo Liu, Xiao‐Xiao Huang, et al.. (2021). Flavonoid-triazolyl hybrids as potential anti-hepatitis C virus agents: Synthesis and biological evaluation. European Journal of Medicinal Chemistry. 218. 113395–113395. 9 indexed citations
9.
Wang, Shu, Yingshi Zhang, Tianshu Ren, et al.. (2020). A novel 4-aminoquinazoline derivative, DHW-208, suppresses the growth of human breast cancer cells by targeting the PI3K/AKT/mTOR pathway. Cell Death and Disease. 11(6). 491–491. 26 indexed citations
10.
Fan, Yanhua, Huaiwei Ding, Donghwa Kim, et al.. (2020). The PI3Kα inhibitor DFX24 suppresses tumor growth and metastasis in non-small cell lung cancer via ERK inhibition and EPHB6 reactivation. Pharmacological Research. 160. 105147–105147. 11 indexed citations
11.
Liu, Wenwu, Xiaowen Jiang, Yang Yue, et al.. (2020). A comprehensive description of GluN2B-selective N-methyl-D-aspartate (NMDA) receptor antagonists. European Journal of Medicinal Chemistry. 200. 112447–112447. 65 indexed citations
12.
Wang, Qiu, Mengchi Sun, Chang Li, et al.. (2020). A computer-aided chem-photodynamic drugs self-delivery system for synergistically enhanced cancer therapy. Asian Journal of Pharmaceutical Sciences. 16(2). 203–212. 18 indexed citations
13.
Ding, Huaiwei, Shu Wang, Xiaochun Qin, et al.. (2019). Design, synthesis, and biological evaluation of some novel 4-aminoquinazolines as Pan-PI3K inhibitors. Bioorganic & Medicinal Chemistry. 27(13). 2729–2740. 8 indexed citations
14.
Ding, Huaiwei, et al.. (2019). Design, synthesis and evaluation of some 1,6-disubstituted-1H-benzo[d]imidazoles derivatives targeted PI3K as anticancer agents. Bioorganic Chemistry. 93. 103283–103283. 19 indexed citations
15.
Ding, Huaiwei, Chenglong Deng, Dandan Li, et al.. (2018). Design, synthesis and biological evaluation of novel 4-aminoquinazolines as dual target inhibitors of EGFR-PI3Kα. European Journal of Medicinal Chemistry. 146. 460–470. 20 indexed citations
16.
Fan, Yanhua, Huaiwei Ding, Dandan Liu, et al.. (2018). Novel 4-aminoquinazoline derivatives induce growth inhibition, cell cycle arrest and apoptosis via PI3Kα inhibition. Bioorganic & Medicinal Chemistry. 26(8). 1675–1685. 29 indexed citations
17.
Liu, Dandan, Chenglong Deng, Xiaochun Qin, et al.. (2018). Design, synthesis and biological evaluation of novel series of 2H-benzo[b][1,4]oxazin-3(4H)-one and 2H-benzo[b][1,4]oxazine scaffold derivatives as PI3Kα inhibitors. Bioorganic & Medicinal Chemistry. 26(14). 3982–3991. 4 indexed citations
18.
Ding, Huaiwei, Kai Chen, Chenglong Deng, et al.. (2017). Synthesis and Smo Activity of Some Novel Benzamide Derivatives. Molecules. 23(1). 85–85. 4 indexed citations
19.
Fan, Yanhua, Wei Li, Dandan Liu, et al.. (2017). Design, synthesis, and biological evaluation of novel 3-substituted imidazo[1,2- a ]pyridine and quinazolin-4(3H)-one derivatives as PI3Kα inhibitors. European Journal of Medicinal Chemistry. 139. 95–106. 40 indexed citations
20.
Zhang, Cunlong, et al.. (2012). Selective VEGFR Inhibitors for Anticancer Therapeutics in Clinical Use and Clinical Trials. Current Pharmaceutical Design. 18(20). 2921–2935. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kwan‐Young Jung Breakdown of academic impact, for papers by Teresa Valero Breakdown of academic impact, for papers by Jinqian Liu Breakdown of academic impact, for papers by Yohei Saito Breakdown of academic impact, for papers by Amir Faisal Breakdown of academic impact, for papers by Hormoz Mazdiyasni Breakdown of academic impact, for papers by Darren McKerrecher Breakdown of academic impact, for papers by Dan Mao Breakdown of academic impact, for papers by Massimo Serra Breakdown of academic impact, for papers by Chi Meng
Rankless by CCL
2026